{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:17:44Z","timestamp":1790741864719,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38182-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:33:45Z","timestamp":1770197625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of choroidal hypertransmission and retinal pigment epithelium loss for quantification of geographic atrophy across commonly used SD-OCT devices"],"prefix":"10.1038","volume":"16","author":[{"given":"Anna","family":"Eidenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Frank-Publig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schrittwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Tratnig-Frankl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gumpinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"38182_CR1","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","volume":"106","author":"JS Sunness","year":"1999","unstructured":"Sunness, J. S. et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 106, 1768\u20131779 (1999).","journal-title":"Ophthalmology"},{"key":"38182_CR2","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier, J. S. et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. The Lancet 402, 1434\u20131448 (2023).","journal-title":"The Lancet"},{"key":"38182_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani, A. M. et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. The Lancet 402, 1449\u20131458 (2023).","journal-title":"The Lancet"},{"key":"38182_CR4","doi-asserted-by":"crossref","unstructured":"G\u00f6bel, A. P., Fleckenstein, M., Schmitz-Valckenberg, S., Brinkmann, C. K. & Holz, F. G. Imaging geographic atrophy in age-related macular degeneration. Ophthalmologica 226, 182\u2013190 (2011).","DOI":"10.1159\/000330420"},{"key":"38182_CR5","doi-asserted-by":"crossref","unstructured":"Schmidt-Erfurth, U., Klimscha, S., Waldstein, S. M. & Bogunovi\u0107, H. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Eye (Lond). 31, 26\u201344 (2017).","DOI":"10.1038\/eye.2016.227"},{"key":"38182_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/IAE.0000000000003974","volume":"44","author":"BU Pandya","year":"2023","unstructured":"Pandya, B. U., Grinton, M., Mandelcorn, E. D. & Felfeli, T. Retinal optical coherence tomography imaging biomarkers: A review of the literature. Retina 44, 369\u2013380 (2023).","journal-title":"Retina"},{"key":"38182_CR7","doi-asserted-by":"crossref","unstructured":"Guymer, R. H. et al. Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: Classification of atrophy meeting report 4. Ophthalmology 127, 394\u2013409 (2020).","DOI":"10.1016\/j.ophtha.2019.09.035"},{"key":"38182_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/ph18030284","volume":"18","author":"ML Enzendorfer","year":"2025","unstructured":"Enzendorfer, M. L. et al. Rethinking Clinical Trials in Age-Related Macular Degeneration: How AI-Based OCT Analysis Can Support Successful Outcomes. Pharmaceuticals 18,\u00a0284 (2025).","journal-title":"Pharmaceuticals"},{"key":"38182_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101305","volume":"103","author":"GS Reiter","year":"2024","unstructured":"Reiter, G. S. et al. AI in the clinical management of GA: A novel therapeutic universe requires novel tools. Prog. Retin. Eye. Res. 103, 101305 (2024).","journal-title":"Prog Retin Eye Res"},{"key":"38182_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100456","volume":"4","author":"K Kostolna","year":"2024","unstructured":"Kostolna, K. et al. A systematic prospective comparison of fluid volume evaluation across OCT devices used in clinical practice. Ophthalmol. Sci.\u00a04, 100456 (2024).","journal-title":"Ophthalmol. Sci."},{"key":"38182_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2020.2914","volume":"138","author":"M Pfau","year":"2020","unstructured":"Pfau, M. et al. Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration. JAMA Ophthalmol. 138, 1026\u20131034\u00a0(2020).","journal-title":"JAMA Ophthalmol"},{"key":"38182_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.oret.2020.07.006","volume":"5","author":"SC Cleland","year":"2021","unstructured":"Cleland, S. C. et al. Quantification of geographic atrophy using spectral domain OCT in age-related macular degeneration. Ophthalmol. Retina. 5, 41\u201348 (2021).","journal-title":"Ophthalmol. Retina"},{"key":"38182_CR13","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41598-023-34139-2","volume":"13","author":"J Mai","year":"2023","unstructured":"Mai, J. et al. Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment. Sci. Rep. 13,\u00a07028 (2023).","journal-title":"Sci. Rep."},{"key":"38182_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1167\/iovs.66.4.65","volume":"66","author":"S Frank-Publig","year":"2025","unstructured":"Frank-Publig, S. et al. Quantifications of outer retinal bands in geographic atrophy by comparing superior axial resolution and conventional OCT. Invest. Ophthalmol. Vis. Sci. 66,\u00a065 (2025).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"38182_CR15","doi-asserted-by":"crossref","unstructured":"Morsy, M. S. et al. Comparison of ultra-high speed 250 kHz OCTA with high speed 125 kHz mode using Heidelberg spectralis SHIFT: A paired-eye analysis. Retina (2025).","DOI":"10.1097\/IAE.0000000000004751"},{"key":"38182_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1109\/RBME.2010.2084567","volume":"3","author":"MD Abr\u00e0moff","year":"2010","unstructured":"Abr\u00e0moff, M. D., Garvin, M. K. & Sonka, M. Retinal imaging and image analysis. IEEE Rev. Biomed. Eng. 3, 169\u2013208 (2010).","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"38182_CR17","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00216-011-5008-1","volume":"400","author":"S Marschall","year":"2011","unstructured":"Marschall, S., Sander, B., Mogensen, M., J\u00f8rgensen, T. M. & Andersen, P. E. Optical coherence tomography\u2014current technology and applications in clinical and biomedical research. Anal. Bioanal. Chem. 400, 2699\u20132720. (2011).","journal-title":"Anal Bioanal Chem"},{"key":"38182_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oret.2023.10.011","volume":"8","author":"A Mahmoudi","year":"2024","unstructured":"Mahmoudi, A. et al. Atrophic lesions associated with age-related macular degeneration. Ophthalmol. Retina. 8, 367\u2013375 (2024).","journal-title":"Ophthalmol Retina"},{"key":"38182_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajo.2021.11.001","volume":"237","author":"R Laiginhas","year":"2022","unstructured":"Laiginhas, R. et al. Persistent hypertransmission defects detected on En face swept source optical computed tomography images predict the formation of geographic atrophy in age-related macular degeneration. Am. J. Ophthalmol. 237, 58\u201370 (2022).","journal-title":"Am. J. Ophthalmol."},{"key":"38182_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.oret.2022.01.011","volume":"6","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Diagnosing persistent hypertransmission defects on En face OCT imaging of age-related macular degeneration. Ophthalmol. Retina. 6, 387\u2013397 (2022).","journal-title":"Ophthalmol. Retina."},{"key":"38182_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/bjophthalmol-2013-303904","volume":"98","author":"S Copete","year":"2014","unstructured":"Copete, S., Flores-Moreno, I., Montero, J. A., Duker, J. S. & Ruiz-Moreno, J. M. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br. J. Ophthalm.\u00a098, 334\u2013338 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"38182_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.oret.2023.07.021","volume":"7","author":"S Schmitz-Valckenberg","year":"2023","unstructured":"Schmitz-Valckenberg, S. et al. Interreader agreement and longitudinal progression of incomplete\/complete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration. Ophthalmol. Retina. 7, 1059\u20131068 (2023).","journal-title":"Ophthalmol Retina"},{"key":"38182_CR23","doi-asserted-by":"crossref","unstructured":"Wu, Z. et al. OCT signs of early atrophy in age-related macular degeneration: Interreader agreement: Classification of atrophy meetings report 6. Ophthalmol. Retina. 6, 4\u201314 (2022).","DOI":"10.1016\/j.oret.2021.03.008"},{"key":"38182_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.oret.2022.03.017","volume":"6","author":"SB Velaga","year":"2022","unstructured":"Velaga, S. B., Nittala, M. G., Hariri, A. & Sadda, S. R. Correlation between fundus autofluorescence and En Face OCT measurements of geographic atrophy. Ophthalmol. Retina. 6, 676\u2013683 (2022).","journal-title":"Ophthalmol. Retina."},{"key":"38182_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.oret.2021.02.004","volume":"5","author":"Y Shi","year":"2021","unstructured":"Shi, Y., Yang, J., Feuer, W., Gregori, G. & Rosenfeld, P. J. Persistent hypertransmission defects on En face OCT imaging as a stand-alone precursor for the future formation of geographic atrophy. Ophthalmol. Retina. 5, 1214\u20131225 (2021).","journal-title":"Ophthalmol. Retina."},{"key":"38182_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajo.2022.06.023","volume":"244","author":"J Mai","year":"2022","unstructured":"Mai, J. et al. Comparison of fundus Autofluorescence versus optical coherence tomography\u2013based evaluation of the therapeutic response to Pegcetacoplan in geographic atrophy. Am. J. Ophthalmol. 244, 175\u2013182 (2022).","journal-title":"Am J Ophthalmol"},{"key":"38182_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ophtha.2024.08.017","volume":"132","author":"U Schmidt-Erfurth","year":"2025","unstructured":"Schmidt-Erfurth, U. et al. Disease activity and therapeutic response to Pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT. Ophthalmology 132, 181\u2013193 (2025).","journal-title":"Ophthalmology"},{"key":"38182_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000515148","volume":"244","author":"Y Yang","year":"2021","unstructured":"Yang, Y. & Dunbar, H. Clinical perspectives and trends: Microperimetry as a trial endpoint in retinal disease. Ophthalmologica\u00a0244, 418\u2013450\u00a0(2021).","journal-title":"Ophthalmologica"},{"key":"38182_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.66.3.26","volume":"66","author":"K Birner","year":"2025","unstructured":"Birner, K. et al. Structure-function correlation of deep-learning quantified ellipsoid zone and retinal pigment epithelium loss and microperimetry in geographic atrophy. Invest. Ophthalmol. Vis. Sci. 66,\u00a026 (2025).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"38182_CR30","doi-asserted-by":"crossref","unstructured":"Riedl, S. et al. The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence\u2013based OCT analysis. Ophthalmol. Retina. 6, 1009\u20131018 (2022).","DOI":"10.1016\/j.oret.2022.05.030"},{"key":"38182_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/eye.2016.260","volume":"31","author":"SB Velaga","year":"2017","unstructured":"Velaga, S. B. et al. Impact of optical coherence tomography scanning density on quantitative analyses in neovascular age-related macular degeneration. Eye (Lond). 31, 53\u201361. (2017).","journal-title":"Eye"},{"key":"38182_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162001","volume":"11","author":"L Terry","year":"2016","unstructured":"Terry, L. et al. Automated retinal layer segmentation using spectral domain optical coherence tomography: Evaluation of Inter-session repeatability and agreement between devices. PLoS ONE 11,\u00a0e0162001 (2016).","journal-title":"PLoS ONE"},{"key":"38182_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41433-021-01490-5","volume":"36","author":"S Chandra","year":"2022","unstructured":"Chandra, S., Rasheed, R., Sen, P., Menon, D. & Sivaprasad, S. Inter-rater reliability for diagnosis of geographic atrophy using spectral domain OCT in age-related macular degeneration. Eye\u00a0(Lond).\u00a036, 392\u2013397 (2022).","journal-title":"Eye"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38182-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:13:48Z","timestamp":1771586028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38182"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38182-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AE, KB, SFP,  JS, MTF, MG: none USE: AbbVie (C), ADARx (C), Alcon (C), Alkeus (C), Allergan (C), Annexon (C), Apellis (C, F), Astellas (C), Aviceda  (C), Bayer (C), Boehringer Ingelheim (C), Complement Therapeutics (C), EcoR1 (C), Galimedix (C), Genentech (F) Heidelberg Engineering (F), Janssen (C), Kodiak (C, F), Medscape (C), ONL (C), RetInSight (F), Roche (C, F), Topcon (C).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7240"}}